Extracorporeal circulatory support in near-fatal flecainide overdose

Anaesthesia and Intensive Care

Volumn 27, Issue 4, 1999, Pages 405-408

  Corkeron, M A ^a   Van Heerden, P V ^a   Newman, S M A J ^a   Dusci, L ^a  

^a SIR CHARLES GAIRDNER HOSPITAL   (Australia)

Author keywords

Antiarrhythmics: flecainide, overdose

Indexed keywords

ANTIARRHYTHMIC AGENT; BICARBONATE; FLECAINIDE; INOTROPIC AGENT; PARACETAMOL;

ADULT; ARTICLE; BLOOD CLOTTING DISORDER; CARDIOPULMONARY BYPASS; CASE REPORT; DRUG OVERDOSE; EXTRACORPOREAL CIRCULATION; FEMALE; HEART FAILURE; HEMODIALYSIS; HUMAN; INTRAVASCULAR HEMOLYSIS; KIDNEY FAILURE; MORTALITY; RESUSCITATION; SHOCK;

EID: 0032843952     PISSN: 0310057X     EISSN: None     Source Type: Journal    
DOI: 10.1177/0310057x9902700413     Document Type: Article

References (17)

1. Falk RH, Fogel RI. Flecainide. J Cardiovasc Electrophysiol 1994; 5:964-981.
2. Pottage A. Clinical profiles of newer class 1 antiarrhythmic agents tocainide, mexilitine, encainide, flecainide and lorcainide. Am J Cardiol 1983; 52:24C-31C.
3. Sangrador G, Sanchez-Alcaraz A, Rodriguez M, Ibanez P. Clinical pharmacokinetics of intravenous flecainide in critically ill patients. J Clin Pharm Ther 1989; 14:309-314.
4. Forland SC, Cutler RE, McQuinn RL, Kvam DC, Miller AM, Conard GJ, Parish S. Flecainide pharmacokinetics after multiple dosing in patients with impaired renal function. J Clin Pharmacol 1988; 28:727-735.
5. Boriani G, Capucci A, Strocchi E, Calliva R, Santarelli A, Biffi M, Magnani B. Flecainide acetate: concentration-response relationships for antiarrhythmic and electrocardiographic effects. Int J Clin Pharmacol Res 1993; 13:211-219.
6. Padrini R, Piovan D, Busa M, al-Bunni M, Maiolino P, Ferrari M. Pharmacodynamic variability of flecainide assessed by QRS changes. Clin Pharmacol Ther 1993; 53:59-64.
7. Kennerdy A, Thomas P, Sheridan DJ. Generalised seizures as the presentation of flecainide toxicity. Eur Heart J 1989; 10:950-954.
8. Yasui RK, Culclasure TF, Kaufman D, Freed CR. Flecainide overdose . . . is cardiopulmonary support the treatment? Ann Emerg Med 1997; 29:680-682.
9. Rogers C, Anderson DT, Sathyavagiswaran L. Fatal flecainide intoxication. J Anal Toxicol 1993; 17:434-435.
10. Koppel C, Oberdisse U, Heinemeyer G. Clinical course and outcome in class 1 C antiarrhthmic overdose. J Toxicol Clin Toxicol 1990;28:433-444.
11. Braun J, Kollert JR, Gessler U, Becker JU. Failure of haemoperfusion to reduce flecainide intoxication. Med Toxicol Adverse Drug Exp 1987; 2:463-467.
12. Gotz D, Pohle S, Barckow D. Primary and secondary detoxification in severe flecainide intoxication. Intensive Care Med 1991; 17:181-184.
13. Goldman MJ, Mowry JB, Kirk MA. Sodium bicarbonate to correct widened ORS in a case of flecainide overdose. J Emerg Med 1997;15:183-186.
14. Lovecchio F, Berlin R, Brubacher JR, Sholar JB. Hypertonic sodium bicarbonate in an acute flecainide overdose. Am J Emerg Med 1998;16:534-537.
15. Bou-Abboud E, Nattel S. Relative role of alkalosis and sodium ions in reversal of class 1 antiarrhythmic drug-induced sodium channel blockade by sodium bicarbonate. Circulation 1996;94: 1954-1961
16. Pond SM. Extracorporeal techniques in the treatment of poisoned patients. Med J Aust 1991; 154:62-63.
17. Kuhlkamp V, Haasis R, Seipel L. Flecainide induced hepatitis (abstract). Z Kardiol 1988; 77:678-680.